Mary E. Vail

819 total citations
19 papers, 602 citations indexed

About

Mary E. Vail is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Mary E. Vail has authored 19 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 8 papers in Oncology. Recurrent topics in Mary E. Vail's work include Axon Guidance and Neuronal Signaling (8 papers), Angiogenesis and VEGF in Cancer (7 papers) and Liver physiology and pathology (5 papers). Mary E. Vail is often cited by papers focused on Axon Guidance and Neuronal Signaling (8 papers), Angiogenesis and VEGF in Cancer (7 papers) and Liver physiology and pathology (5 papers). Mary E. Vail collaborates with scholars based in Australia, United States and Belgium. Mary E. Vail's co-authors include Peter W. Janes, Andrew M. Scott, Robert H. Pierce, Nelson Fausto, Martin Lackmann, Stephen R. Plymate, K S Evans, Lakmali Atapattu, Cynthia C.T. Sprenger and N Fausto and has published in prestigious journals such as The Journal of Cell Biology, PLoS ONE and Cancer Research.

In The Last Decade

Mary E. Vail

19 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary E. Vail Australia 12 335 163 163 114 82 19 602
Suihai Wang China 15 482 1.4× 32 0.2× 133 0.8× 43 0.4× 57 0.7× 25 745
Lindsey N. Jackson United States 15 473 1.4× 35 0.2× 210 1.3× 33 0.3× 69 0.8× 19 856
Kunihiko Tatsumi Japan 8 296 0.9× 50 0.3× 282 1.7× 36 0.3× 16 0.2× 8 663
Sudhakiranmayi Kuravi United States 11 502 1.5× 127 0.8× 52 0.3× 35 0.3× 24 0.3× 17 665
Wen-Juan Gan China 15 554 1.7× 59 0.4× 258 1.6× 80 0.7× 18 0.2× 31 912
Yoshiaki Sunami Germany 12 274 0.8× 21 0.1× 251 1.5× 50 0.4× 62 0.8× 36 705
Raquel Parı́s Spain 8 608 1.8× 19 0.1× 215 1.3× 98 0.9× 27 0.3× 8 836
Liangru Contois United States 8 238 0.7× 18 0.1× 52 0.3× 74 0.6× 28 0.3× 10 409
Rosemary C. McFall United States 15 374 1.1× 20 0.1× 170 1.0× 51 0.4× 24 0.3× 23 880
Linfang Wang China 13 312 0.9× 97 0.6× 133 0.8× 62 0.5× 22 0.3× 37 575

Countries citing papers authored by Mary E. Vail

Since Specialization
Citations

This map shows the geographic impact of Mary E. Vail's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Vail with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Vail more than expected).

Fields of papers citing papers by Mary E. Vail

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E. Vail. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Vail. The network helps show where Mary E. Vail may publish in the future.

Co-authorship network of co-authors of Mary E. Vail

This figure shows the co-authorship network connecting the top 25 collaborators of Mary E. Vail. A scholar is included among the top collaborators of Mary E. Vail based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary E. Vail. Mary E. Vail is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Burvenich, Ingrid J.G., Christian Wichmann, Angela Rigopoulos, et al.. (2024). Targeting of immune checkpoint regulator V-domain Ig suppressor of T-cell activation (VISTA) with 89Zr-labelled CI-8993. European Journal of Nuclear Medicine and Molecular Imaging. 51(13). 3863–3873. 2 indexed citations
2.
Vail, Mary E., Rae H. Farnsworth, Linda Hii, et al.. (2023). Inhibition of EphA3 Expression in Tumour Stromal Cells Suppresses Tumour Growth and Progression. Cancers. 15(18). 4646–4646. 8 indexed citations
3.
Vail, Mary E., Linda Hii, Paul J. McMurrick, et al.. (2022). Preferential Antibody and Drug Conjugate Targeting of the ADAM10 Metalloprotease in Tumours. Cancers. 14(13). 3171–3171. 7 indexed citations
4.
Janes, Peter W., Mary E. Vail, Matthias Ernst, & Andrew M. Scott. (2020). Eph Receptors in the Immunosuppressive Tumor Microenvironment. Cancer Research. 81(4). 801–805. 41 indexed citations
5.
Janes, Peter W., Mary E. Vail, Hui Gan, & Andrew M. Scott. (2020). Antibody Targeting of Eph Receptors in Cancer. Pharmaceuticals. 13(5). 88–88. 29 indexed citations
6.
Vail, Mary E., Carmel Murone, Linda Hii, et al.. (2014). Targeting EphA3 Inhibits Cancer Growth by Disrupting the Tumor Stromal Microenvironment. Cancer Research. 74(16). 4470–4481. 67 indexed citations
7.
Farnsworth, Rae H., Mary E. Vail, Caroline E. Gargett, et al.. (2014). Hypoxia-Controlled EphA3 Marks a Human Endometrium-Derived Multipotent Mesenchymal Stromal Cell that Supports Vascular Growth. PLoS ONE. 9(11). e112106–e112106. 18 indexed citations
8.
Janes, Peter W., Christopher Slape, Rae H. Farnsworth, et al.. (2014). EphA3 biology and cancer. Growth Factors. 32(6). 176–189. 53 indexed citations
9.
Atapattu, Lakmali, Nayanendu Saha, Mary E. Vail, et al.. (2012). Antibodies binding the ADAM10 substrate recognition domain inhibit Eph function. Journal of Cell Science. 125(24). 6084–6093. 34 indexed citations
10.
Abramson, David, Colin Enticott, Stephen Firth, et al.. (2011). Integrating Scientific Workflows and Large Tiled Display Walls: Bridging the Visualization Divide. 308–316. 2 indexed citations
11.
Nievergall, Eva, Peter W. Janes, Mary E. Vail, et al.. (2010). PTP1B regulates Eph receptor function and trafficking. The Journal of Cell Biology. 191(6). 1189–1203. 55 indexed citations
12.
Abramson, David, Colin Enticott, Stephen Firth, et al.. (2010). An abstract virtual instrument system for high throughput automatic microscopy. Procedia Computer Science. 1(1). 545–554. 5 indexed citations
13.
Abramson, David, Colin Enticott, Stephen Firth, et al.. (2009). Virtual Microscopy and Analysis Using Scientific Workflows. 239–246. 5 indexed citations
14.
15.
Pierce, Robert H., et al.. (2002). Bcl-2 Expression Inhibits Liver Carcinogenesis and Delays the Development of Proliferating Foci. American Journal Of Pathology. 160(5). 1555–1560. 55 indexed citations
16.
Vail, Mary E., Michelle Chaisson, James Thompson, & Nelson Fausto. (2002). Bcl-2 expression delays hepatocyte cell cycle progression during liver regeneration. Oncogene. 21(10). 1548–1555. 34 indexed citations
17.
Adams, Michael L., Robert H. Pierce, Mary E. Vail, et al.. (2001). Enhanced Acetaminophen Hepatotoxicity in Transgenic Mice Overexpressing BCL-2. Molecular Pharmacology. 60(5). 907–915. 85 indexed citations
18.
Adams, Michael L., Robert H. Pierce, Mary E. Vail, et al.. (2001). Enhanced Acetaminophen Hepatotoxicity in Transgenic Mice Overexpressing BCL-2. Molecular Pharmacology. 60(5). 907–915. 1 indexed citations
19.
Vail, Mary E., Robert H. Pierce, & N Fausto. (2001). Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha.. PubMed. 61(2). 594–601. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suihai Wang Breakdown of academic impact, for papers by Lindsey N. Jackson Breakdown of academic impact, for papers by Kunihiko Tatsumi Breakdown of academic impact, for papers by Sudhakiranmayi Kuravi Breakdown of academic impact, for papers by Wen-Juan Gan Breakdown of academic impact, for papers by Yoshiaki Sunami Breakdown of academic impact, for papers by Raquel Parı́s Breakdown of academic impact, for papers by Liangru Contois Breakdown of academic impact, for papers by Rosemary C. McFall Breakdown of academic impact, for papers by Linfang Wang
Rankless by CCL
2026